Table of Contents

Introduction to the hematopoietic growth factors.
Early-acting hematopoietic growth factors: biology and clinical experience.
Granulocyte colony-stimulating factors.
Erythropoiesis-stimulating agents.
Thrombopoietin factors.
Cyclic and chronic neutropenia.
The myeloid growth factors.
Meta-analysis of randomized controlled trials of granulocyte colony-stimulating factor prophylaxis in adult cancer patients receiving chemotherapy.
Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy.
Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.
Do erythropoietic-stimulating agents relieve fatigue?: a review of reviews.
Randomized controlled trials of the erythroid-stimulating agents in cancer patients.
Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients.
Clinical practice guidelines for the use of erythroid-stimulating agents: ASCO, EORTC, NCCN.
Thrombocytopenia and platelet transfusions in patients with cancer.
Romiplostim.
Eltrombopag.
The hematopoietic growth factors in acute leukemia: US perspective.
The hematopoietic growth factors in acute leukemia: a European perspective.
The hematopoietic growth factors in the myelodysplastic syndromes.
Hematopoietic growth factors in older cancer patients.
The economics of the hematopoietic growth factors.